Enhancement of renal excretion of zinc by hydrochlorothiazide

Charles Y C Pak, Belle Ruskin, Esther Diller

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The effect of hydrochlorothiazide (50 mg twice a day orally for 5 days) on the metabolism of zinc was examined in four patients with idiopathic hypercalciuria, one with idiopathic osteoporosis, one with normocalciuric nephrolithiasis, one normal volunteer, and one with normocalcemic primary hyperparathyroidism. Urinary zinc progressively increased until the peak value, at approximately twice the mean of control values, was reached on the fifth day of treatment with hydrochlorothiazide. After treatment was stopped, it gradually decreased towards control values. Serum concentration of zinc increased slightly or did not change during treatment. In contrast, furosemide, triamterene, mercaptomerin, or oral "sodium loading" did not affect renal excretion of zinc.

Original languageEnglish (US)
Pages (from-to)511-517
Number of pages7
JournalClinica Chimica Acta
Volume39
Issue number2
DOIs
StatePublished - 1972

Fingerprint

Hydrochlorothiazide
Zinc
Triamterene
Hypercalciuria
Nephrolithiasis
Primary Hyperparathyroidism
Furosemide
Metabolism
Osteoporosis
Healthy Volunteers
Therapeutics
Sodium
Renal Elimination
Serum

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry

Cite this

Enhancement of renal excretion of zinc by hydrochlorothiazide. / Pak, Charles Y C; Ruskin, Belle; Diller, Esther.

In: Clinica Chimica Acta, Vol. 39, No. 2, 1972, p. 511-517.

Research output: Contribution to journalArticle

Pak, Charles Y C ; Ruskin, Belle ; Diller, Esther. / Enhancement of renal excretion of zinc by hydrochlorothiazide. In: Clinica Chimica Acta. 1972 ; Vol. 39, No. 2. pp. 511-517.
@article{151b5274421d4168938c165496644ebe,
title = "Enhancement of renal excretion of zinc by hydrochlorothiazide",
abstract = "The effect of hydrochlorothiazide (50 mg twice a day orally for 5 days) on the metabolism of zinc was examined in four patients with idiopathic hypercalciuria, one with idiopathic osteoporosis, one with normocalciuric nephrolithiasis, one normal volunteer, and one with normocalcemic primary hyperparathyroidism. Urinary zinc progressively increased until the peak value, at approximately twice the mean of control values, was reached on the fifth day of treatment with hydrochlorothiazide. After treatment was stopped, it gradually decreased towards control values. Serum concentration of zinc increased slightly or did not change during treatment. In contrast, furosemide, triamterene, mercaptomerin, or oral {"}sodium loading{"} did not affect renal excretion of zinc.",
author = "Pak, {Charles Y C} and Belle Ruskin and Esther Diller",
year = "1972",
doi = "10.1016/0009-8981(72)90080-0",
language = "English (US)",
volume = "39",
pages = "511--517",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Enhancement of renal excretion of zinc by hydrochlorothiazide

AU - Pak, Charles Y C

AU - Ruskin, Belle

AU - Diller, Esther

PY - 1972

Y1 - 1972

N2 - The effect of hydrochlorothiazide (50 mg twice a day orally for 5 days) on the metabolism of zinc was examined in four patients with idiopathic hypercalciuria, one with idiopathic osteoporosis, one with normocalciuric nephrolithiasis, one normal volunteer, and one with normocalcemic primary hyperparathyroidism. Urinary zinc progressively increased until the peak value, at approximately twice the mean of control values, was reached on the fifth day of treatment with hydrochlorothiazide. After treatment was stopped, it gradually decreased towards control values. Serum concentration of zinc increased slightly or did not change during treatment. In contrast, furosemide, triamterene, mercaptomerin, or oral "sodium loading" did not affect renal excretion of zinc.

AB - The effect of hydrochlorothiazide (50 mg twice a day orally for 5 days) on the metabolism of zinc was examined in four patients with idiopathic hypercalciuria, one with idiopathic osteoporosis, one with normocalciuric nephrolithiasis, one normal volunteer, and one with normocalcemic primary hyperparathyroidism. Urinary zinc progressively increased until the peak value, at approximately twice the mean of control values, was reached on the fifth day of treatment with hydrochlorothiazide. After treatment was stopped, it gradually decreased towards control values. Serum concentration of zinc increased slightly or did not change during treatment. In contrast, furosemide, triamterene, mercaptomerin, or oral "sodium loading" did not affect renal excretion of zinc.

UR - http://www.scopus.com/inward/record.url?scp=0015369895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015369895&partnerID=8YFLogxK

U2 - 10.1016/0009-8981(72)90080-0

DO - 10.1016/0009-8981(72)90080-0

M3 - Article

C2 - 5043786

AN - SCOPUS:0015369895

VL - 39

SP - 511

EP - 517

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

IS - 2

ER -